This report aims to provide a comprehensive presentation of the global market for CAR T-Cell Therapy, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR T-Cell Therapy.

The CAR T-Cell Therapy market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global CAR T-Cell Therapy market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR T-Cell Therapy manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global CAR T-Cell Therapy market size in 2022 is 1900.00 million US dollars, and it is expected to be 4902.21 million US dollars by 2029, with a compound annual growth rate of 14.50% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the CAR T-Cell Therapy market include Autolus Therapeutics, CARsgen Therapeutics Co.Ltd., Juno Therapeutics, Inc., Sorrento Therapeutics, Inc., and Bluebird bio, Inc.. The share of the top 3 players in the CAR T-Cell Therapy market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of CAR T-Cell Therapy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Axicabtagene Ciloleucel accounted for XX% of CAR T-Cell Therapy market in 2022. Tisagenlecleucel43 share of XX%.
Acute Lymphocytic Leukaemia accounted for XX% of the CAR T-Cell Therapy market in 2022. Chronic Lymphocytic Leukaemia accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapters 2-4: Segmented the global CAR T-Cell Therapy market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa CAR T-Cell Therapy market country revenue data, and includes PEST Analysis.
Chapter 10: Analysis of the competitive environment of CAR T-Cell Therapy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the CAR T-Cell Therapy industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapters 12-14: Provide detailed CAR T-Cell Therapy market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 15: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Autolus Therapeutics
CARsgen Therapeutics Co.Ltd.
Juno Therapeutics, Inc.
Sorrento Therapeutics, Inc.
Bluebird bio, Inc.
CELGENE CORPORATION
Eureka Therapeutics Inc.
Avacta Life Sciences Ltd.
Calyxt Inc.
Celyad Oncology SA
Fortress Biotech, Inc
IMMUNE THERAPEUTICS, INC
Gilead Sciences, Inc.
Novartis AG
Alaunos Therapeutics, Inc.

Types list
Axicabtagene Ciloleucel
Tisagenlecleucel43
Brexucabtagene Autoleucel
Lisocabtagene Maraleuce
Idecabtagene Vicleucel
Ciltacabtegene Autoleucel
Others

Application list
Acute Lymphocytic Leukaemia
Chronic Lymphocytic Leukaemia
Diffuse Large B-Cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Glioblastoma
Sarcoma
Neuroblastoma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer
Others

Table of Content

1 CAR T-Cell Therapy Market Introduction and Overview
1.1 CAR T-Cell Therapy Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 CAR T-Cell Therapy Industry Dynamic Analysis
1.5.1 CAR T-Cell Therapy Market Trends Analysis
1.5.2 CAR T-Cell Therapy Market Drivers Analysis
1.5.3 CAR T-Cell Therapy Market Challenges Analysis
1.5.4 CAR T-Cell Therapy Market Restraints Analysis
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
1.8 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global CAR T-Cell Therapy Market Insights by Type
2.1 Market Size Insights by Types
2.2 Global CAR T-Cell Therapy Revenue and Share by Type
3 Global CAR T-Cell Therapy Market Insights by Application
3.1 Market Size Insights by Application
3.2 Global CAR T-Cell Therapy Revenue and Share by Application (2018-2023)
4 Global Market Growth Insights
4.1 Global CAR T-Cell Therapy Market Size (2018-2023)
4.2 CAR T-Cell Therapy Growth Insights by Regions
4.2.1 CAR T-Cell Therapy Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 CAR T-Cell Therapy Revenue Market Size by Regions (2018-2023)
4.2.3 North America CAR T-Cell Therapy Market Size (2018-2023)
4.2.4 Europe CAR T-Cell Therapy Market Size (2018-2023)
4.2.5 Asia-Pacific CAR T-Cell Therapy Market Size (2018-2023)
4.2.6 Latin America CAR T-Cell Therapy Market Size (2018-2023)
4.2.7 Middle East & Africa CAR T-Cell Therapy Market Size (2018-2023)
5 North America
5.1 North America CAR T-Cell Therapy Revenue by Countries
5.1.1 North America CAR T-Cell Therapy Revenue by Countries (2018-2023)
5.2 North America PEST Analysis
5.3 United States
5.4 Canada
6 Asia Pacific
6.1 Asia Pacific CAR T-Cell Therapy Revenue by Countries
6.1.1 Asia Pacific CAR T-Cell Therapy Revenue by Countries (2018-2023)
6.2 Asia-Pacific PEST Analysis
6.3 China
6.4 Japan
6.5 Korea
6.6 Southeast Asia
6.7 India
6.8 Australia
7 Europe
7.1 Europe CAR T-Cell Therapy Revenue by Countries
7.1.1 Europe CAR T-Cell Therapy Revenue by Countries (2018-2023)
7.2 Europe PEST Analysis
7.3 Germany
7.4 France
7.5 UK
7.6 Italy
7.7 Russia
7.8 Spain
7.9 Nordic
8 Latin America
8.1 Latin America CAR T-Cell Therapy Revenue by Countries
8.1.1 Latin America CAR T-Cell Therapy Revenue by Countries (2018-2023)
8.2 Latin America PEST Analysis
8.3 Brazil
8.4 Argentina
8.5 Mexico
9 Middle East & Africa
9.1 Middle East & Africa CAR T-Cell Therapy Revenue by Countries
9.1.1 Middle East & Africa CAR T-Cell Therapy Revenue by Countries (2018-2023)
9.2 Middle East & Africa PEST Analysis
9.3 Egypt
9.4 South Africa
9.5 UAE
9.6 Turkey
9.7 Saudi Arabia
10 Global CAR T-Cell Therapy Market Competition, by Players
10.1 Global CAR T-Cell Therapy Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 CAR T-Cell Therapy Players Market Share in 2022
10.2.2 Top 6 CAR T-Cell Therapy Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 CAR T-Cell Therapy Players Head Office, Business Provided
10.4 CAR T-Cell Therapy Mergers & Acquisitions
10.5 CAR T-Cell Therapy New Entrants and Expansion Plans
11 Players Profiles
11.1 Autolus Therapeutics
11.1.1 Autolus Therapeutics Company Profile
11.1.2 CAR T-Cell Therapy Product Overview
11.1.3 Autolus Therapeutics CAR T-Cell Therapy Market Performance (2018-2023)
11.1.4 Autolus Therapeutics Business Overview
11.1.5 Recent Developments and Plans
11.2 CARsgen Therapeutics Co.Ltd.
11.2.1 CARsgen Therapeutics Co.Ltd. Company Profile
11.2.2 CAR T-Cell Therapy Product Overview
11.2.3 CARsgen Therapeutics Co.Ltd. CAR T-Cell Therapy Market Performance (2018-2023)
11.2.4 CARsgen Therapeutics Co.Ltd. Business Overview
11.2.5 Recent Developments and Plans
11.3 Juno Therapeutics, Inc.
11.3.1 Juno Therapeutics, Inc. Company Profile
11.3.2 CAR T-Cell Therapy Product Overview
11.3.3 Juno Therapeutics, Inc. CAR T-Cell Therapy Market Performance (2018-2023)
11.3.4 Juno Therapeutics, Inc. Business Overview
11.3.5 Recent Developments and Plans
11.4 Sorrento Therapeutics, Inc.
11.4.1 Sorrento Therapeutics, Inc. Company Profile
11.4.2 CAR T-Cell Therapy Product Overview
11.4.3 Sorrento Therapeutics, Inc. CAR T-Cell Therapy Market Performance (2018-2023)
11.4.4 Sorrento Therapeutics, Inc. Business Overview
11.4.5 Recent Developments and Plans
11.5 Bluebird bio, Inc.
11.5.1 Bluebird bio, Inc. Company Profile
11.5.2 CAR T-Cell Therapy Product Overview
11.5.3 Bluebird bio, Inc. CAR T-Cell Therapy Market Performance (2018-2023)
11.5.4 Bluebird bio, Inc. Business Overview
11.5.5 Recent Developments and Plans
11.6 CELGENE CORPORATION
11.6.1 CELGENE CORPORATION Company Profile
11.6.2 CAR T-Cell Therapy Product Overview
11.6.3 CELGENE CORPORATION CAR T-Cell Therapy Market Performance (2018-2023)
11.6.4 CELGENE CORPORATION Business Overview
11.6.5 Recent Developments and Plans
11.7 Eureka Therapeutics Inc.
11.7.1 Eureka Therapeutics Inc. Company Profile
11.7.2 CAR T-Cell Therapy Product Overview
11.7.3 Eureka Therapeutics Inc. CAR T-Cell Therapy Market Performance (2018-2023)
11.7.4 Eureka Therapeutics Inc. Business Overview
11.7.5 Recent Developments and Plans
11.8 Avacta Life Sciences Ltd.
11.8.1 Avacta Life Sciences Ltd. Company Profile
11.8.2 CAR T-Cell Therapy Product Overview
11.8.3 Avacta Life Sciences Ltd. CAR T-Cell Therapy Market Performance (2018-2023)
11.8.4 Avacta Life Sciences Ltd. Business Overview
11.8.5 Recent Developments and Plans
11.9 Calyxt Inc.
11.9.1 Calyxt Inc. Company Profile
11.9.2 CAR T-Cell Therapy Product Overview
11.9.3 Calyxt Inc. CAR T-Cell Therapy Market Performance (2018-2023)
11.9.4 Calyxt Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 Celyad Oncology SA
11.10.1 Celyad Oncology SA Company Profile
11.10.2 CAR T-Cell Therapy Product Overview
11.10.3 Celyad Oncology SA CAR T-Cell Therapy Market Performance (2018-2023)
11.10.4 Celyad Oncology SA Business Overview
11.10.5 Recent Developments and Plans
11.11 Fortress Biotech, Inc
11.11.1 Fortress Biotech, Inc Company Profile
11.11.2 CAR T-Cell Therapy Product Overview
11.11.3 Fortress Biotech, Inc CAR T-Cell Therapy Market Performance (2018-2023)
11.11.4 Fortress Biotech, Inc Business Overview
11.11.5 Recent Developments and Plans
11.12 IMMUNE THERAPEUTICS, INC
11.12.1 IMMUNE THERAPEUTICS, INC Company Profile
11.12.2 CAR T-Cell Therapy Product Overview
11.12.3 IMMUNE THERAPEUTICS, INC CAR T-Cell Therapy Market Performance (2018-2023)
11.12.4 IMMUNE THERAPEUTICS, INC Business Overview
11.12.5 Recent Developments and Plans
11.13 Gilead Sciences, Inc.
11.13.1 Gilead Sciences, Inc. Company Profile
11.13.2 CAR T-Cell Therapy Product Overview
11.13.3 Gilead Sciences, Inc. CAR T-Cell Therapy Market Performance (2018-2023)
11.13.4 Gilead Sciences, Inc. Business Overview
11.13.5 Recent Developments and Plans
11.14 Novartis AG
11.14.1 Novartis AG Company Profile
11.14.2 CAR T-Cell Therapy Product Overview
11.14.3 Novartis AG CAR T-Cell Therapy Market Performance (2018-2023)
11.14.4 Novartis AG Business Overview
11.14.5 Recent Developments and Plans
11.15 Alaunos Therapeutics, Inc.
11.15.1 Alaunos Therapeutics, Inc. Company Profile
11.15.2 CAR T-Cell Therapy Product Overview
11.15.3 Alaunos Therapeutics, Inc. CAR T-Cell Therapy Market Performance (2018-2023)
11.15.4 Alaunos Therapeutics, Inc. Business Overview
11.15.5 Recent Developments and Plans
12 Global CAR T-Cell Therapy Forecast Market Insights by Type
12.1 Global CAR T-Cell Therapy Revenue Market Forecast by Type (2023-2029)
13 Global CAR T-Cell Therapy Forecast Market Insights by Application
13.1 CAR T-Cell Therapy Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Insights
14.1 Global CAR T-Cell Therapy Forecast Market Size (2023-2029)
14.2 CAR T-Cell Therapy Growth Forecast Insights by Regions
14.2.1 CAR T-Cell Therapy Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America CAR T-Cell Therapy Forecast Market Size (2023-2029)
14.2.3 Europe CAR T-Cell Therapy Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific CAR T-Cell Therapy Forecast Market Size (2023-2029)
14.2.5 Latin America CAR T-Cell Therapy Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa CAR T-Cell Therapy Forecast Market Size (2023-2029)
15 Methodology and Data Source
15.1 A Methodology
15.1.1 Research Process
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 B Data Source
15.2.1 Legal Disclaimer

List of Tables and Figures

Figure CAR T-Cell Therapy Picture
Table Product Definition of CAR T-Cell Therapy
Table Economic Analysis of Global Regions
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global CAR T-Cell Therapy Market Size by Type (2018 VS 2023 VS 2029)
Table Global CAR T-Cell Therapy Revenue by Type (2018-2023)
Table Global CAR T-Cell Therapy Revenue and Share by Type (2018-2023)
Table Global CAR T-Cell Therapy Market Size by Application (2018 VS 2023 VS 2029)
Table Global CAR T-Cell Therapy Revenue by Application (2018-2023)
Table Global CAR T-Cell Therapy Revenue Share by Application (2018-2023)
Figure Global CAR T-Cell Therapy Revenue Market Size Growth (2018-2023)
Table CAR T-Cell Therapy Market Size by Regions: 2018 VS 2023 VS 2029
Table CAR T-Cell Therapy Revenue Market Size by Regions (2018-2023)
Table CAR T-Cell Therapy Revenue and Share by Regions (2018-2023)
Figure North America CAR T-Cell Therapy Market Size (2018-2023)
Figure Europe CAR T-Cell Therapy Market Size (2018-2023)
Figure Asia-Pacific CAR T-Cell Therapy Market Size (2018-2023)
Figure Latin America CAR T-Cell Therapy Market Size (2018-2023)
Figure Middle East & Africa CAR T-Cell Therapy Market Size (2018-2023)
Table North America CAR T-Cell Therapy Revenue by Countries (2018-2023)
Table North America CAR T-Cell Therapy Revenue and Share by Countries (2018-2023)
Table North America PEST Analysis
Figure United States CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Canada CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Canada CAR T-Cell Therapy Sales and Growth (2018-2023)
Table Asia-Pacific CAR T-Cell Therapy Revenue by Countries (2018-2023)
Table Asia-Pacific CAR T-Cell Therapy Revenue and Share by Countries (2018-2023)
Table Asia-Pacific PEST Analysis
Figure China CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Japan CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Korea CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Southeast Asia CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure India CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Australia CAR T-Cell Therapy Revenue and Growth (2018-2023)
Table Europe CAR T-Cell Therapy Revenue by Countries (2018-2023)
Table Europe CAR T-Cell Therapy Revenue and Share by Countries (2018-2023)
Table Europe PEST Analysis
Figure Germany CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure France CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure UK CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Italy CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Russia CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Spain CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Nordic CAR T-Cell Therapy Revenue and Growth (2018-2023)
Table Latin America CAR T-Cell Therapy Revenue by Countries (2018-2023)
Table Latin America CAR T-Cell Therapy Revenue and Share by Countries (2018-2023)
Table Latin America PEST Analysis
Figure Brazil CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Argentina CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Mexico CAR T-Cell Therapy Revenue and Growth (2018-2023)
Table Middle East & Africa CAR T-Cell Therapy Revenue by Countries (2018-2023)
Table Middle East & Africa CAR T-Cell Therapy Revenue and Share by Countries (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Egypt CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure South Africa CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure UAE CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Turkey CAR T-Cell Therapy Revenue and Growth (2018-2023)
Figure Saudi Arabia CAR T-Cell Therapy Revenue and Growth (2018-2023)
Table Global CAR T-Cell Therapy Revenue by Players (2018-2023)
Table Global CAR T-Cell Therapy Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global CAR T-Cell Therapy Players Market Concentration Ratio (CR5) (2018-2023)
Table CAR T-Cell Therapy Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Autolus Therapeutics Profile
Table Product Overview
Table Autolus Therapeutics CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Autolus Therapeutics Revenue and Growth Rate
Figure Autolus Therapeutics Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table CARsgen Therapeutics Co.Ltd. Profile
Table Product Overview
Table CARsgen Therapeutics Co.Ltd. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure CARsgen Therapeutics Co.Ltd. Revenue and Growth Rate
Figure CARsgen Therapeutics Co.Ltd. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Juno Therapeutics, Inc. Profile
Table Product Overview
Table Juno Therapeutics, Inc. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Juno Therapeutics, Inc. Revenue and Growth Rate
Figure Juno Therapeutics, Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Sorrento Therapeutics, Inc. Profile
Table Product Overview
Table Sorrento Therapeutics, Inc. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Sorrento Therapeutics, Inc. Revenue and Growth Rate
Figure Sorrento Therapeutics, Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bluebird bio, Inc. Profile
Table Product Overview
Table Bluebird bio, Inc. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Bluebird bio, Inc. Revenue and Growth Rate
Figure Bluebird bio, Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table CELGENE CORPORATION Profile
Table Product Overview
Table CELGENE CORPORATION CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure CELGENE CORPORATION Revenue and Growth Rate
Figure CELGENE CORPORATION Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Eureka Therapeutics Inc. Profile
Table Product Overview
Table Eureka Therapeutics Inc. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Eureka Therapeutics Inc. Revenue and Growth Rate
Figure Eureka Therapeutics Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Avacta Life Sciences Ltd. Profile
Table Product Overview
Table Avacta Life Sciences Ltd. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Avacta Life Sciences Ltd. Revenue and Growth Rate
Figure Avacta Life Sciences Ltd. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Calyxt Inc. Profile
Table Product Overview
Table Calyxt Inc. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Calyxt Inc. Revenue and Growth Rate
Figure Calyxt Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Celyad Oncology SA Profile
Table Product Overview
Table Celyad Oncology SA CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Celyad Oncology SA Revenue and Growth Rate
Figure Celyad Oncology SA Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Fortress Biotech, Inc Profile
Table Product Overview
Table Fortress Biotech, Inc CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Fortress Biotech, Inc Revenue and Growth Rate
Figure Fortress Biotech, Inc Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table IMMUNE THERAPEUTICS, INC Profile
Table Product Overview
Table IMMUNE THERAPEUTICS, INC CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure IMMUNE THERAPEUTICS, INC Revenue and Growth Rate
Figure IMMUNE THERAPEUTICS, INC Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Gilead Sciences, Inc. Profile
Table Product Overview
Table Gilead Sciences, Inc. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Gilead Sciences, Inc. Revenue and Growth Rate
Figure Gilead Sciences, Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Novartis AG Profile
Table Product Overview
Table Novartis AG CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Novartis AG Revenue and Growth Rate
Figure Novartis AG Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Alaunos Therapeutics, Inc. Profile
Table Product Overview
Table Alaunos Therapeutics, Inc. CAR T-Cell Therapy Revenue, Gross and Gross Margin (2018-2023)
Figure Alaunos Therapeutics, Inc. Revenue and Growth Rate
Figure Alaunos Therapeutics, Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global CAR T-Cell Therapy Revenue Forecast by Type (2023-2029)
Table Global CAR T-Cell Therapy Revenue and Share Forecast by Type (2023-2029)
Table Global CAR T-Cell Therapy Revenue by Application (2023-2029)
Table Global CAR T-Cell Therapy Revenue and Share by Application (2023-2029)
Figure Global CAR T-Cell Therapy Revenue Forecast Market Size (2023-2029)
Table CAR T-Cell Therapy Revenue Forecast by Regions (2023-2029)
Table CAR T-Cell Therapy Revenue and Share Forecast by Regions (2023-2029)
Figure North America CAR T-Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Europe CAR T-Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific CAR T-Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Latin America CAR T-Cell Therapy Revenue Forecast Market Size (2023-2029)
Figure Middle East & Africa CAR T-Cell Therapy Revenue Forecast Market Size (2023-2029)
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report